Celgene Corporation

Registered Principal Details

Cessation Date
4/23/2014 12:00:00 AM

Business Or Interest:
Biopharmaceutical company.

Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.

CEO Name:
Bob Hugin
Director of State Government Relations

Contact
HF
Helen Fitzpatrick
86 Morris Ave
Summit, NJ 07901
(312) 330-2884
jmannion@skadden.com
http://www.celgene.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 392
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

For
Notification Date
9/30/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 300
Senate Bill 300
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)

Bill Text and History

2013 Wisconsin Act 186

For
Notification Date
9/17/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Access to Oral Anticancer Medications
Development, drafting or introduction of a proposal relating to
Access to Oral Anticancer Medications

Action Intended To Affect
Legislative matter

Notification Date
5/23/2013
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2013
January - June		 2013
July - December		 2014
January - June		 2014
July - December		 Total
Total Lobbying Expenditures 2013
January - June $21,739.97		 2013
July - December $26,912.27		 2014
January - June $20,938.91		 2014
July - December $251.88		 Total $69,843.02
Total Hours Communicating 2013
January - June 41.25		 2013
July - December 51.50		 2014
January - June 29.00		 2014
July - December 0.00		 Total 121.75
Total Hours Other 2013
January - June 92.50		 2013
July - December 128.75		 2014
January - June 117.25		 2014
July - December 4.00		 Total 342.50

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Senate Bill 300
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June		 2013
July - December		 2014
January - June		 2014
July - December		 Total
2013
January - June 		2013
July - December 42%		 2014
January - June 50%		 2014
July - December 		Total 32%
Assembly Bill 392
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy. (FE)
2013
January - June		 2013
July - December		 2014
January - June		 2014
July - December		 Total
2013
January - June 		2013
July - December 58%		 2014
January - June 		2014
July - December 		Total 23%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

Access to Oral Anticancer Medications
2013
January - June		 2013
July - December		 2014
January - June		 2014
July - December		 Total
2013
January - June 100%		 2013
July - December 		2014
January - June 50%		 2014
July - December 100%		 Total 45%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures

2013

January - June
July - December

2014

January - June
July - December